The New York and Presbyterian Hospital

The New York and Presbyterian Hospital was paid $207.37M by Medicaid between Jan 2018 and Dec 2024, across 745 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 9.5% of everything it billed.

33Billing provider infoTHE NEW YORK AND PRESBYTERIAN HOSPITAL
NEW YORK, NY 10065

33aNPI1952332801assigned 07/06/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$207.37M

24GClaims3,132,313

24DCodes billed745

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#6 of 231

Median peer was paid$561K

This provider vs. median370×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	32,423	$1.46M
2019	161,216	$8.53M
2020	335,841	$19.18M
2021	439,200	$26.57M
2022	578,705	$37.55M
2023	872,442	$62.43M
2024incomplete	712,486	$51.64M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	9.5%	99,662	90,054	$19.76M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	7.7%	83,851	76,828	$15.96M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.6%	74,895	68,592	$13.73M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	5.0%	58,533	55,842	$10.40M
J9271	Injection, pembrolizumab, 1 mg	3.9%	942	743	$8.19M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.5%	39,328	32,407	$7.27M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.3%	42,177	40,277	$6.91M
96361	Intravenous infusion, hydration; each additional hour	3.0%	21,289	19,850	$6.17M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	2.1%	22,551	19,867	$4.43M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2.0%	1,175	1,075	$4.14M
70450	Computed tomography, head or brain; without contrast material	1.8%	12,514	12,005	$3.66M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.6%	5,672	5,636	$3.38M

733 more codes

J3380	Injection, vedolizumab, intravenous, 1 mg	1.6%	819	$3.28M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.6%	17,719	$3.22M
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.5%	3,827	$3.20M
J7170	Injection, emicizumab-kxwh, 0.5 mg	1.5%	104	$3.13M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.3%	25,971	$2.75M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	13,978	$2.63M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.2%	8,846	$2.46M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	1.1%	11,250	$2.29M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	1.1%	3,193	$2.23M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.0%	13,003	$2.11M
G2067	Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)	<1%	9,504	$2.06M
36430		<1%	4,607	$1.81M
96415		<1%	2,997	$1.76M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	8,660	$1.75M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,841	$1.63M
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	1,110	$1.59M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,404	$1.57M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	23,542	$1.53M
80053	Comprehensive metabolic panel	<1%	80,582	$1.53M
90791	Psychiatric diagnostic evaluation	<1%	1,590	$1.45M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,806	$1.33M
H0020	Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)	<1%	34,290	$1.25M
86850		<1%	27,474	$1.23M
80048	Basic metabolic panel (calcium, ionized)	<1%	80,836	$1.22M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	5,743	$1.17M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,510	$1.16M
80076		<1%	52,006	$1.15M
H2012	Behavioral health day treatment, per hour	<1%	10,897	$1.14M
77336		<1%	2,423	$1.13M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	7,773	$1.09M
99205	Prolong outpt/office vis	<1%	5,373	$1.07M
93458		<1%	604	$1.03M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	32,072	$1.01M
G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	<1%	8,305	$970K
87486		<1%	24,202	$858K
59025	Fetal non-stress test	<1%	2,994	$843K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	8,012	$832K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	594	$824K
86901		<1%	28,978	$788K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,045	$770K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	3,798	$761K
93970		<1%	1,403	$757K
86900		<1%	31,284	$734K
80061	Lipid panel	<1%	32,445	$734K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	413	$723K
97161		<1%	4,162	$663K
36415	Collection of venous blood by venipuncture	<1%	122,466	$648K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	32,081	$640K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	3,826	$596K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	434	$588K
90834	Psychotherapy session, about 45 minutes	<1%	3,234	$587K
77386		<1%	2,909	$580K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,974	$567K
87536		<1%	10,010	$567K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	8,175	$545K
93975		<1%	803	$517K
J0897	Injection, denosumab, 1 mg	<1%	362	$510K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	2,839	$506K
77412		<1%	1,462	$488K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	5,311	$484K
87581		<1%	24,171	$474K
12001		<1%	929	$470K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	24,565	$463K
12011		<1%	831	$444K
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	445	$437K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	14,778	$430K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	15,951	$427K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	11,381	$427K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,257	$425K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	237	$418K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,232	$412K
77334		<1%	1,123	$406K
19301		<1%	156	$379K
58558		<1%	273	$378K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	493	$375K
82803		<1%	17,114	$360K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	775	$355K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	670	$344K
76770		<1%	652	$341K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	234	$336K
J2323	Injection, natalizumab, 1 mg	<1%	49	$329K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	9,175	$328K
16020		<1%	651	$328K
97803		<1%	7,756	$313K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	695	$310K
10060		<1%	798	$295K
99385		<1%	1,584	$294K
96367		<1%	2,897	$288K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	349	$288K
86480		<1%	4,738	$282K
83880		<1%	10,149	$268K
99386		<1%	1,534	$268K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	15,408	$262K
90686		<1%	14,389	$254K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	18,377	$226K
97802		<1%	4,352	$218K
76830	Ultrasound, transvaginal	<1%	5,112	$217K
90715		<1%	8,729	$212K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	5,378	$209K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	8,130	$199K
47562		<1%	67	$192K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,009	$192K
88342		<1%	2,668	$191K
J3490	Unclassified drugs	<1%	1,545	$185K
90651		<1%	2,970	$176K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,047	$175K
96416		<1%	220	$169K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	26,025	$167K
77300		<1%	735	$167K
90677		<1%	3,032	$165K
36416		<1%	6,372	$163K
J0185	Injection, aprepitant, 1 mg	<1%	1,949	$159K
93351		<1%	361	$146K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	827	$140K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	864	$135K
96402		<1%	1,569	$124K
J1756	Injection, iron sucrose, 1 mg	<1%	2,500	$123K
20610		<1%	414	$122K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	98	$122K
90750		<1%	935	$119K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	346	$117K
87799		<1%	5,000	$117K
43235		<1%	166	$115K
77290		<1%	274	$115K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	120,014	$115K
93971		<1%	1,733	$112K
77338		<1%	298	$111K
97165		<1%	815	$110K
70486		<1%	1,819	$109K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	182	$109K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	3,876	$106K
90832	Psychotherapy session, about 30 minutes	<1%	807	$104K
96417		<1%	2,927	$104K
42830		<1%	61	$102K
70496		<1%	334	$99K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	43	$98K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	53,575	$97K
29125		<1%	356	$96K
J2505	Injection, pegfilgrastim, 6 mg	<1%	40	$95K
91322		<1%	1,270	$94K
96409		<1%	1,296	$94K
71250		<1%	560	$94K
86902		<1%	2,728	$92K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,353	$90K
97535	Self-care/home management training, each 15 minutes	<1%	1,054	$89K
96375	Therapeutic injection; each additional sequential IV push	<1%	20,936	$89K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	761	$89K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	934	$88K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	731	$87K
97116		<1%	1,456	$87K
71046	Radiologic examination, chest; 2 views	<1%	22,165	$83K
85610		<1%	31,620	$83K
70491		<1%	264	$82K
99381		<1%	389	$81K
90697		<1%	3,180	$80K
58100		<1%	132	$80K
87497		<1%	3,597	$80K
12002		<1%	154	$78K
83655		<1%	5,073	$76K
86359		<1%	3,399	$76K
54161		<1%	69	$75K
86360		<1%	3,353	$74K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,236	$73K
19083		<1%	44	$73K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	167	$72K
87507		<1%	1,161	$72K
83970		<1%	2,390	$67K
G0397	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes	<1%	397	$66K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	492	$65K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	340	$64K
92551		<1%	710	$63K
90670		<1%	5,247	$61K
96411		<1%	1,870	$60K
86923		<1%	2,933	$58K
86356		<1%	1,808	$58K
76000		<1%	1,325	$57K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	17,347	$57K
38222		<1%	111	$56K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	703	$53K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,105	$52K
99401		<1%	632	$50K
58662		<1%	37	$50K
84443	Thyroid stimulating hormone (TSH)	<1%	27,214	$49K
83036	Hemoglobin; glycosylated (A1C)	<1%	28,310	$47K
77332		<1%	114	$46K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	223	$46K
C1781	Mesh (implantable)	<1%	301	$46K
76098		<1%	209	$45K
71045	Radiologic examination, chest; single view	<1%	9,303	$45K
C1769	Guide wire	<1%	3,299	$44K
Q0139	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)	<1%	182	$44K
90681		<1%	3,641	$44K
77001		<1%	113	$44K
76942		<1%	229	$44K
99383		<1%	210	$43K
88307		<1%	657	$43K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	354	$43K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	609	$42K
86355		<1%	2,257	$42K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	211	$41K
92526		<1%	210	$41K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	201	$41K
90656		<1%	3,248	$40K
77301		<1%	246	$40K
90619		<1%	1,162	$40K
81025		<1%	11,864	$39K
99384		<1%	197	$38K
20611		<1%	65	$38K
90698		<1%	4,236	$38K
73700		<1%	171	$37K
90836		<1%	353	$37K
D1110	Prophylaxis - adult	<1%	364	$37K
86357		<1%	2,244	$37K
87653		<1%	1,630	$36K
30140		<1%	12	$35K
J7050	Infusion, normal saline solution, 250 cc	<1%	17,156	$35K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	275	$35K
0001A		<1%	1,148	$35K
90633		<1%	3,474	$34K
J9070	Cyclophosphamide, 100 mg	<1%	182	$33K
96401		<1%	625	$33K
0124A		<1%	889	$33K
49650		<1%	13	$33K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	14,697	$32K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	27,962	$32K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,542	$31K
82728		<1%	12,377	$31K
87522	Neg quan hep c or qual rna	<1%	870	$30K
77065	Tomosynthesis, mammo	<1%	336	$30K
85027		<1%	24,755	$28K
90707		<1%	1,997	$28K
86769		<1%	1,597	$28K
52356		<1%	13	$27K
93976		<1%	41	$27K
77373		<1%	38	$27K
0002A		<1%	773	$26K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	31	$26K
72197		<1%	49	$25K
76937		<1%	122	$25K
29130		<1%	93	$25K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,322	$24K
87517		<1%	867	$23K
90716		<1%	1,806	$23K
J9267	Injection, paclitaxel, 1 mg	<1%	1,393	$23K
86880		<1%	855	$23K
81001		<1%	34,259	$23K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	633	$23K
86803		<1%	11,303	$23K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	92	$22K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	3,115	$22K
76819	Fetal biophysical profile; without non-stress testing	<1%	333	$22K
85055		<1%	622	$22K
84439		<1%	10,377	$22K
90480		<1%	1,074	$21K
86922		<1%	684	$21K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	12,576	$21K
87086	Culture, bacterial; quantitative colony count, urine	<1%	24,609	$21K
82962		<1%	24,577	$21K
T1023	Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter	<1%	364	$21K
C1874	Stent, coated/covered, with delivery system	<1%	70	$21K
84403		<1%	2,406	$21K
H0001	Alcohol and/or drug assessment	<1%	112	$20K
77063	Screening digital breast tomosynthesis, bilateral	<1%	642	$20K
82607		<1%	7,367	$20K
82784		<1%	5,176	$20K
80047		<1%	1,085	$19K
96376		<1%	3,836	$19K
99242		<1%	88	$19K
84702		<1%	13,044	$19K
72141		<1%	100	$18K
83735		<1%	22,603	$18K
83615		<1%	10,757	$18K
J9045	Injection, carboplatin, 50 mg	<1%	1,014	$18K
90674		<1%	609	$18K
36561		<1%	14	$18K
Q3014	Telehealth originating site facility fee	<1%	1,504	$18K
90734		<1%	1,392	$18K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,821	$18K
58300		<1%	93	$18K
92610		<1%	95	$17K
J3489	Injection, zoledronic acid, 1 mg	<1%	413	$17K
84484		<1%	29,532	$17K
96377		<1%	365	$17K
76999		<1%	224	$16K
77280		<1%	41	$16K
88341		<1%	1,053	$16K
86592		<1%	17,496	$16K
87631		<1%	252	$16K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	196	$16K
70487		<1%	50	$16K
85730		<1%	23,390	$16K
J7030	Infusion, normal saline solution , 1000 cc	<1%	13,314	$16K
90710		<1%	1,300	$16K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	48	$15K
85014		<1%	16,656	$15K
90732		<1%	428	$15K
86870		<1%	355	$15K
54150		<1%	14	$15K
90744		<1%	1,788	$15K
74178		<1%	69	$15K
87481		<1%	596	$14K
70547		<1%	28	$14K
91321		<1%	291	$14K
90696		<1%	1,244	$14K
50200		<1%	12	$14K
96161		<1%	255	$14K
87340		<1%	9,631	$14K
0003A		<1%	361	$14K
90620		<1%	616	$14K
36591		<1%	186	$13K
0054A		<1%	369	$13K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	408	$13K
72131		<1%	97	$13K
94375		<1%	161	$13K
76870		<1%	542	$13K
96156		<1%	47	$12K
88112		<1%	247	$12K
70498		<1%	289	$12K
90658		<1%	955	$12K
96368		<1%	685	$11K
94726		<1%	68	$11K
81513		<1%	412	$11K
J8540	Dexamethasone, oral, 0.25 mg	<1%	5,799	$11K
84153		<1%	2,944	$11K
74183		<1%	51	$11K
51798		<1%	29	$11K
84100		<1%	11,283	$11K
86334		<1%	2,272	$10K
83540		<1%	10,692	$10K
83550		<1%	10,243	$10K
31575		<1%	543	$10K
73562		<1%	4,140	$10K
83605		<1%	19,161	$10K
96450		<1%	13	$10K
51741		<1%	29	$10K
99243		<1%	46	$10K
99173		<1%	367	$10K
82670		<1%	908	$9K
83883		<1%	3,302	$9K
82043		<1%	7,506	$9K
99051		<1%	603	$9K
84703		<1%	6,484	$9K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	700	$9K
76857		<1%	574	$9K
97162		<1%	50	$9K
82378		<1%	1,992	$8K
82746		<1%	3,389	$8K
D0120	Dental checkup, returning patient	<1%	91	$8K
80197		<1%	3,313	$8K
78815	Positron emission tomography (PET) for limited area imaging	<1%	13	$8K
86706		<1%	4,698	$8K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	514	$8K
83516		<1%	1,849	$8K
85045		<1%	5,397	$8K
94729		<1%	277	$8K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	21	$8K
J9370	Vincristine sulfate, 1 mg	<1%	861	$7K
0134A		<1%	173	$7K
81003		<1%	20,163	$7K
86140		<1%	9,693	$7K
83020		<1%	2,211	$7K
64615		<1%	12	$7K
C1760	Closure device, vascular (implantable/insertable)	<1%	293	$7K
90381		<1%	158	$7K
86704		<1%	4,515	$7K
97760		<1%	71	$7K
86765		<1%	3,489	$7K
88360		<1%	88	$7K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,451	$7K
J0690	Injection, cefazolin sodium, 500 mg	<1%	7,627	$7K
0072A		<1%	162	$6K
92523		<1%	26	$6K
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,685	$6K
90694		<1%	494	$6K
76818		<1%	64	$6K
99406		<1%	97	$6K
86762		<1%	3,209	$6K
80329		<1%	2,396	$6K
83690		<1%	21,413	$6K
87529		<1%	227	$6K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	15,696	$6K
99429		<1%	491	$6K
83001		<1%	1,406	$6K
J1453	Injection, fosaprepitant, 1 mg	<1%	39	$6K
94010		<1%	44	$6K
82330		<1%	11,494	$6K
J2704	Injection, propofol, 10 mg	<1%	29,253	$6K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	41	$6K
90691		<1%	82	$5K
90680		<1%	579	$5K
88304		<1%	994	$5K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	49	$5K
93270		<1%	35	$5K
86787		<1%	3,069	$5K
29515		<1%	19	$5K
73610		<1%	3,375	$5K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,240	$5K
87040		<1%	6,401	$5K
0071A		<1%	130	$5K
93017		<1%	27	$5K
84550		<1%	4,473	$5K
86708		<1%	3,126	$5K
0064A		<1%	152	$5K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	29	$5K
90648		<1%	326	$5K
86780		<1%	1,640	$5K
99245		<1%	25	$5K
73630		<1%	3,280	$5K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	314	$4K
90792	Psychiatric diagnostic evaluation with medical services	<1%	18	$4K
96127		<1%	1,251	$4K
86703		<1%	278	$4K
90700		<1%	245	$4K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,602	$4K
83002		<1%	971	$4K
84146		<1%	1,102	$4K
93226		<1%	18	$4K
84165		<1%	2,313	$4K
80320		<1%	5,416	$4K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	5,454	$4K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	4,812	$4K
87070		<1%	6,040	$4K
C1729	Catheter, drainage	<1%	259	$4K
96160		<1%	122	$4K
85652		<1%	7,769	$4K
73030		<1%	2,429	$4K
A9585	Injection, gadobutrol, 0.1 ml	<1%	944	$3K
90380		<1%	71	$3K
J8501	Aprepitant, oral, 5 mg	<1%	541	$3K
83021		<1%	998	$3K
71270		<1%	27	$3K
99382		<1%	17	$3K
82105		<1%	1,886	$3K
73110		<1%	2,374	$3K
C1819	Surgical tissue localization and excision device (implantable)	<1%	72	$3K
73130		<1%	2,733	$3K
90746		<1%	103	$3K
87077		<1%	3,659	$3K
90649		<1%	104	$3K
D6999		<1%	15	$3K
85379		<1%	4,509	$3K
86709		<1%	2,071	$3K
73502		<1%	1,489	$3K
C1726	Catheter, balloon dilatation, non-vascular	<1%	12	$3K
87625		<1%	496	$3K
77012		<1%	15	$3K
89051		<1%	785	$3K
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	3,523	$3K
90672		<1%	179	$3K
86300		<1%	678	$3K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	46	$3K
84436		<1%	1,839	$3K
93304		<1%	15	$3K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	91	$3K
D9999	Unspecified adjunctive procedure, by report	<1%	16	$3K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	18	$3K
85018		<1%	4,544	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	20,065	$2K
82977		<1%	1,755	$2K
82570		<1%	4,261	$2K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	1,019	$2K
88142		<1%	92	$2K
87186		<1%	4,086	$2K
86735		<1%	711	$2K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	465	$2K
73590		<1%	1,783	$2K
86039		<1%	1,154	$2K
84445		<1%	65	$2K
82550		<1%	2,939	$2K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	3,518	$2K
OP250		<1%	1,509	$2K
82950		<1%	2,244	$2K
93325		<1%	32	$2K
J9190	Injection, fluorouracil, 500 mg	<1%	113	$2K
86593		<1%	1,612	$2K
90739		<1%	25	$2K
84479		<1%	1,312	$2K
99241		<1%	12	$2K
87533		<1%	92	$2K
84270		<1%	895	$2K
86376		<1%	581	$2K
84156		<1%	2,998	$2K
82248		<1%	1,866	$2K
86800		<1%	491	$2K
C1758	Catheter, ureteral	<1%	518	$2K
76641		<1%	62	$2K
80050	General health panel	<1%	113	$2K
85384		<1%	893	$2K
87081		<1%	3,841	$2K
76801		<1%	12	$2K
72170		<1%	1,636	$2K
90675		<1%	26	$2K
87900		<1%	25	$2K
93225		<1%	30	$2K
86317		<1%	792	$2K
90653		<1%	169	$2K
85245		<1%	54	$1K
73140		<1%	939	$1K
83010		<1%	782	$1K
90657		<1%	99	$1K
80164		<1%	454	$1K
87205		<1%	4,412	$1K
84154		<1%	423	$1K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	153	$1K
82150		<1%	1,074	$1K
83520		<1%	575	$1K
82565		<1%	5,257	$1K
93320		<1%	15	$1K
0111A		<1%	32	$1K
J9394	Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg	<1%	16	$1K
99177		<1%	54	$1K
72100		<1%	1,059	$1K
86665		<1%	829	$1K
86301		<1%	565	$1K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,029	$1K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	14	$1K
82947		<1%	5,158	$1K
86304		<1%	930	$1K
76536		<1%	115	$1K
90611		<1%	83	$1K
86038		<1%	718	$1K
85240		<1%	122	$1K
73560		<1%	561	$1K
84480		<1%	681	$1K
82232		<1%	241	$1K
84145		<1%	1,302	$989.22
86160		<1%	681	$988.79
85246		<1%	55	$984.46
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	592	$977.96
73080		<1%	1,350	$976.48
86335		<1%	30	$947.09
86696		<1%	345	$943.38
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	17,581	$932.38
95886		<1%	13	$929.75
83993		<1%	288	$904.83
90662		<1%	69	$902.14
73090		<1%	1,307	$900.52
87493		<1%	107	$898.95
C9145	Injection, aprepitant, (aponvie), 1 mg	<1%	14	$897.84
91200		<1%	139	$874.86
73552		<1%	611	$873.08
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	14	$857.28
80179		<1%	1,491	$848.72
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	18,216	$776.43
93923		<1%	15	$754.65
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	85	$732.77
74019		<1%	1,077	$718.96
84425		<1%	222	$718.45
84460		<1%	1,514	$716.33
84450		<1%	1,438	$713.67
87147		<1%	2,892	$705.46
87181		<1%	1,148	$704.40
84132		<1%	5,216	$688.22
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	31	$686.31
G0008	Administration of influenza virus vaccine	<1%	694	$682.47
J9073	Injection, cyclophosphamide (dr. reddy's), 5 mg	<1%	17	$661.36
82533		<1%	213	$657.37
90713		<1%	52	$651.00
0112A		<1%	19	$638.00
87102		<1%	982	$619.57
J1644	Injection, heparin sodium, per 1000 units	<1%	3,198	$611.48
84481		<1%	217	$598.98
80178		<1%	260	$587.92
83521		<1%	252	$584.65
84295		<1%	5,759	$580.62
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	4,440	$568.38
83525		<1%	183	$568.18
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,348	$550.44
72128		<1%	13	$538.47
82435		<1%	4,770	$533.11
95940		<1%	12	$522.32
82652		<1%	25	$518.43
0074A		<1%	14	$480.00
88300		<1%	308	$478.70
80177		<1%	127	$466.05
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,122	$449.36
86147		<1%	142	$442.91
90723		<1%	38	$420.33
90621		<1%	24	$417.64
85660		<1%	557	$400.72
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,655	$398.87
86695		<1%	168	$396.02
90678		<1%	19	$388.50
73521		<1%	202	$387.09
91312		<1%	46	$380.66
86003		<1%	25	$358.50
15853		<1%	29	$353.97
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,388	$349.96
87206		<1%	943	$343.84
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	10,653	$340.85
74018		<1%	229	$339.41
D0999	Unspecified diagnostic procedure, by report	<1%	184	$335.23
87593		<1%	24	$331.86
86431		<1%	405	$327.99
73060		<1%	537	$320.65
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	371	$312.32
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	572	$303.04
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	27	$300.89
86235		<1%	164	$297.70
90660		<1%	25	$290.90
86705		<1%	222	$284.79
84590		<1%	158	$272.84
91320		<1%	18	$262.20
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	833	$259.12
0011A		<1%	21	$258.02
J0184	Injection, amisulpride, 1 mg	<1%	148	$257.83
86644		<1%	182	$256.36
86777		<1%	151	$247.77
84630		<1%	223	$246.12
84207		<1%	12	$235.36
87116		<1%	340	$226.18
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	1,036	$221.94
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	15,034	$220.22
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,774	$211.08
71101		<1%	186	$204.67
82985		<1%	207	$193.37
82785		<1%	26	$184.64
82627		<1%	40	$183.45
77080		<1%	12	$181.37
80230		<1%	129	$169.95
86141		<1%	326	$162.74
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	397	$158.57
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,705	$155.85
86256		<1%	91	$154.04
87015		<1%	611	$150.68
86645		<1%	145	$140.48
86580		<1%	29	$140.18
C9399	Unclassified drugs or biologicals	<1%	257	$139.55
73020		<1%	58	$136.51
84681		<1%	82	$134.00
88720		<1%	289	$132.86
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,585	$130.64
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	15	$128.79
86364		<1%	284	$127.25
82610		<1%	159	$125.81
J1956	Injection, levofloxacin, 250 mg	<1%	119	$121.36
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	282	$119.67
J1630	Injection, haloperidol, up to 5 mg	<1%	1,396	$110.85
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,197	$110.21
G0009	Administration of pneumococcal vaccine	<1%	91	$108.06
82010		<1%	589	$107.03
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	399	$105.42
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	27	$104.16
90461		<1%	26	$102.96
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	7,705	$102.96
J3370	Injection, vancomycin hcl, 500 mg	<1%	382	$97.48
72040		<1%	71	$95.71
90634		<1%	12	$94.61
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	12	$91.56
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	25	$84.93
J7642	Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram	<1%	116	$83.69
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	240	$82.90
82247		<1%	151	$81.58
J2060	Injection, lorazepam, 2 mg	<1%	1,667	$80.50
G1003	Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program	<1%	5,592	$78.56
86146		<1%	51	$72.77
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	678	$71.73
86225		<1%	25	$69.51
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	901	$67.94
72082		<1%	68	$67.04
74021		<1%	66	$66.12
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	426	$64.07
82157		<1%	27	$61.48
85347		<1%	211	$53.85
J7070	Infusion, d5w, 1000 cc	<1%	329	$52.36
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	6,096	$47.13
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	5,224	$47.08
82553		<1%	16	$44.07
J7510	Prednisolone oral, per 5 mg	<1%	614	$43.50
84520		<1%	26	$43.41
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	156	$41.01
31231		<1%	29	$40.11
83721		<1%	103	$37.20
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	192	$32.12
72070		<1%	12	$30.75
84300		<1%	13	$28.65
83498		<1%	14	$28.53
J1953	Injection, levetiracetam, 10 mg	<1%	72	$27.00
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	138	$26.29
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	51	$26.14
82626		<1%	13	$25.01
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	43	$22.68
82390		<1%	24	$22.30
J2305	Injection, nitroglycerin, 5 mg	<1%	362	$19.54
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,250	$17.29
C9153	Injection, amisulpride, 1 mg	<1%	39	$16.38
82948		<1%	16	$16.17
85613		<1%	16	$15.80
84134		<1%	94	$15.02
J3411	Injection, thiamine hcl, 100 mg	<1%	174	$13.42
J3480	Injection, potassium chloride, per 2 meq	<1%	72	$12.48
72110		<1%	49	$11.55
J3360	Injection, diazepam, up to 5 mg	<1%	86	$11.42
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	28	$11.24
82657		<1%	64	$10.86
J1940	Injection, furosemide, up to 20 mg	<1%	85	$10.63
82951		<1%	13	$8.84
84157		<1%	12	$8.00
J1171	Injection, hydromorphone, 0.1 mg	<1%	142	$5.36
82465		<1%	102	$5.22
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	66	$4.27
82952		<1%	13	$3.40
J0780	Injection, prochlorperazine, up to 10 mg	<1%	44	$3.30
J1815	Injection, insulin, per 5 units	<1%	339	$3.02
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	152	$1.46
A6448	Light compression bandage, elastic, knitted/woven, width less than three inches, per yard	<1%	24	$1.43
82009		<1%	28	$1.03
82140		<1%	12	$1.00
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	25	$0.09
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	158	$0.08
91300		<1%	23	$0.04
99080		0%	7,397	$0.00
73000		0%	13	$0.00
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	0%	26	$0.00
83695		0%	13	$0.00
J0670	Injection, mepivacaine hydrochloride, per 10 ml	0%	16	$0.00
80321		0%	54	$0.00
87075		0%	14	$0.00
86200		0%	14	$0.00
74170		0%	13	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	14	$0.00
73070		0%	14	$0.00
83718		0%	13	$0.00
80299		0%	15	$0.00
90748		0%	16	$0.00
87184		0%	12	$0.00
G0010	Administration of hepatitis b vaccine	0%	12	$0.00
84446		0%	12	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	13	$0.00
73660		0%	13	$0.00
70544		0%	54	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	92	$0.00
G8510	Screening for depression is documented as negative, a follow-up plan is not required	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBRESLIN, MICHAEL (GROUP SVP, CFO)

Same official

Other billing entities under BRESLIN, MICHAEL

Full network →

Provider	Location	Paid
The New York and Presbyterian Hospital	New York, NY	$454.95M
Newyork-Presbyterian-Queens	Flushing, NY	$116.41M
New York and Presbyterian Hospital	Brooklyn, NY	$49.52M
The New York and Presbyterian Hospital	New York, NY	$6.29M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.